EMA green light for new medicines
by Gary Finnegan: Five new medicines have been recommended for approval at the latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use
by Gary Finnegan: Five new medicines have been recommended for approval at the latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use
by Gary Finnegan: The European Medicines Agency (EMA) has reduced the fees it charges to companies who hold – or apply for – marketing authorisation for medicines.
by Gary Finnegan: Medicines watchdogs on both sides of the Atlantic could significantly step up collaboration if a new transatlantic trade deal is sewn up later this year.
by Gary Finnegan: Researchers in Canada have found that the chance having a heart attack or stroke increases significantly if a patient has been hospitalised for pneumonia –… read more.
by Gary Finnegan: Could years of diabetes research have been in vain? That is the question occupying scientists after the publication of a new study by researchers in… read more.
by Gary Finnegan: One of the commonly circulating forms of the flu virus, which is particularly common among children, could be eliminated, according to researchers at the Duke-NUS… read more.
by Gary Finnegan: A superbug present in hospitals across Europe and the US can become resistant to treatment even without undergoing genetic changes, according to a new study… read more.
by Gary Finnegan: A superbug present in hospitals across Europe and the US can become resistant to treatment even without undergoing genetic changes, according to a new study… read more.
by Gary Finnegan: The number of new medicines for rare diseases approved by EU drug regulators hit a record high in 2014. Of the 82 medicines given the… read more.
by Gary Finnegan: The European Medicines Agency (EMA) is to step up international cooperation on regulating generics. The regulator says it is ready to share assessment reports for… read more.
by Gary Finnegan: An electronic repository for periodic safety update reports (PSURs) and their assessment reports has been launched by the European Medicines Agency (EMA).
by Gary Finnegan: Seven new medicines have approved at the January meeting of the Committee for Medicinal Products for Human Use (CHMP) – the European Medicines Agency’s influential… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.